Federal contractor · TARRYTOWN, NY
REGENERON PHARMACEUTICALS INC
REGENERON PHARMACEUTICALS INC received $280.2M in federal contract obligations in FY2026, on 2 awards. Since FY2017: $6.8B. Its largest customer was Office of Assistant Secretary for Preparedness and Response ($280.2M).
- Obligations · FY2026
- $280.2M
- New awards
- 2
- Sole-source
- 0.0%
- Single offer
- 0.0%
- UEI
- N3F9MH7E6HD6
Spending by fiscal year
Obligations per federal fiscal year (October–September).
- 66.3MFY2017
- 106.2MFY2018
- 174.2MFY2019
- 638.4MFY2020
- 5.6BFY2021
- 494.1KFY2022
- 326.5MFY2023
- 0FY2024
- -331.7MFY2025
- 280.2MFY2026
Top buying agencies
Obligations in FY2026.
- 2 awards
What was bought · Where the work was performed
Obligations in FY2026.
What was bought
- Research & development$280.2M100%
Where the work was performed
- Westchester County, NY$280.2M100%
Integrity signals
Shares of the year's obligations, next to the country's.
- Low competition0.0%US 39% · -$337.5K
- Sole-source awards0.0%US 30% · -$337.5K
- Single-offer competitions0.0%US 8.7% · $0
- Urgency justifications0.0%US 5.1% · $0
A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.
Largest awards
- IGF::OT::IGF$973.6MOffice of Assistant Secretary for Preparedness and Response· Westchester County, NY· Research & development· Sep 28, 2017 – Sep 25, 2026· HHSO100201700016C
- IGF::OT::IGF$8.6MOffice of Assistant Secretary for Preparedness and Response· Westchester County, NY· Research & development· Nov 23, 2016 – Mar 19, 2026· HHSO100201600023C
Subawards
Matched by Unique Entity ID: the first-tier subawards this organization reported as a prime recipient, and those primes reported paying it.
As a prime: who it pays · FY2026
No subawards reported as a prime in FY2026.
As a sub-recipient: who pays it · FY2026
No subawards reported to it in FY2026.
By fiscal year
- FY2021: $891.1K paid out · $0 received
- FY2022: $195.9K paid out · $0 received
Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.
Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 9, 2026, loaded Oct 9, 2026 · Subawards loaded from FY2021.
Teaming partners
Companies this company reported paying, primes that reported paying it, from FFATA subaward reports.
Companies it pays
4 companies · $1.1M reported
- FISHER CLINICAL SERVICES INC$615.7KALLENTOWN, PA · 1 subaward · Scientific research and development services
- DELTAMED SOLUTIONS INC$195.9KBELLE MEAD, NJ · 1 subaward · Scientific research and development services
- CATALENT INDIANA LLC$180KBLOOMINGTON, IN · 1 subaward · Scientific research and development services
Primes that pay it
No prime reported paying it.
Showing the top 3 of each list. Open the profile for potential partners and the full lists.
Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.
Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 9, 2026, loaded Oct 9, 2026 · Subawards loaded from 2021.
Lobbying and PAC activity
Organizations in House lobbying disclosures and FEC records whose names an AI judgment matched to this company. Those records carry no identifier shared with contracts, so every match is by name.
Matched organizations
- REGENERON PHARMACEUTICALS, INC.AI match · 100%
- Lobbying · 2025
- $2.2M
- 23 reports
- Lobbying · 2023–2026
- $6.8M
- $6.8M in its own reports
- PAC giving · 2026
- $76K
- 1 PAC
Lobbying by year
- 2023$1.7M16 reports
- 2024$1.6M16 reports
- 2025$2.2M23 reports
- 2026$1.3M12 reports
Top issues
- Health issues33 reports
- Budget and appropriations15 reports
- Copyright, patent and trademark14 reports
- Medicare and Medicaid14 reports
- Taxation and the Internal Revenue Code12 reports
- Trade (domestic and foreign)6 reports
Who was contacted
- U.S. SENATE44 reports
- U.S. HOUSE OF REPRESENTATIVES43 reports
- Health & Human Services - Dept of (HHS)25 reports
- Treasury - Dept of2 reports
- White House Office2 reports
- Food & Drug Administration (FDA)1 reports
Houses of Congress and federal agencies the reports list as contacted (a report names every one for all its issues).
Lobbying firms hired
- Crane Strategies$700K14 reports
- Stewart Strategies and Solutions, LLC$480K8 reports
- CHECKMATE GOVERNMENT RELATIONS$480K6 reports
- BGR Government Affairs$450K5 reports
- The Washington Tax & Public Policy Group$180K6 reports
- Arnold & Porter Kaye Scholer LLP$50K14 reports
Registrants who are individuals are counted, not named.
PAC giving to candidates by party, 2026 cycle
- Republican$58.5K77%
- Democratic$17.5K23%
PACs sponsored
- REGENERON PHARMACEUTICALS, INC. PAC$277.3K raised this cycle
PACs these organizations sponsor (connected organizations in FEC records). A PAC gives employees' and members' voluntary contributions, not the company's own money.
Lobbying amounts are the filers' own good-faith estimates on quarterly LD-2 reports (the law asks for amounts rounded to $10,000; under $5,000 need not be itemized), latest amendment only. When an organization files its own report, it replaces what outside firms report for it that quarter. Matches are by name. Lobbying and political giving are legal and public: they show engagement with government, not influence over any award. Correlation is not influence: these organizations' lobbying and their contracts are shown side by side, and nothing here implies either affected the other.
Source: Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives), data current to Oct 9, 2026, loaded Oct 9, 2026 · 2023–2026.
Source: Committees, candidates and committee contributions to candidates (Federal Election Commission), data current to Oct 9, 2026, loaded Oct 9, 2026 · 2026, 2024, 2022.
Matches: Analisa AI name judgments (entity-match@1), updated Sep 30, 2026.
Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.